Holdings
Virtus Investment Advisers, LLC
As of Sep 30, 2026, Virtus Investment Advisers, LLC reported 432 positions worth US$423M. Largest: Moderna, Inc., Iovance Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Moderna, Inc. | 33,770 | US$6.5M | +10,470 | Sep 30, 2026 |
| Iovance Biotherapeutics, Inc. | 413K | US$6.12M | +128K | Sep 30, 2026 |
| Regeneron Pharmaceuticals, Inc. | 5,490 | US$4.16M | +1,170 | Sep 30, 2026 |
| Gilead Sciences, Inc. | 27,587 | US$4.11M | +4,219 | Sep 30, 2026 |
| Amgen Inc. | 9,586 | US$4.04M | +1,014 | Sep 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 7,668 | US$4.01M | +5,054 | Sep 30, 2026 |
| Omeros Corporation | 193K | US$3.67M | +59,830 | Sep 30, 2026 |
| Incyte Corporation | 30,177 | US$3.66M | +633 | Sep 30, 2026 |
| BioMarin Pharmaceutical Inc. | 60,783 | US$3.65M | +39,999 | Sep 30, 2026 |
| Verastem, Inc. | 411K | US$3.31M | +127K | Sep 30, 2026 |